Background Medical device certification has undergone significant changes in recent years. However, exploration of stakeholder experiences remains relatively limited, particularly in the context of software as a medical device. This study sought to explore stakeholder experiences of medical device certification across both the UK and EU. Methods Semi-structured interviews (n = 22) analysed using inductive-thematic analysis, synthesised using activity theory. Results Innovators, consultants and notified bodies share more similarities than differences when discussing barriers and enablers to achieving medical device certification. Systemic tensions between existing rules, tools, community understanding and division of labour currentl...
The Poly Implant Prothèse (PIP) scandal in France prompted a revision of the regulations regarding t...
Background Up until 2017, medical devices were placed on the European Union’s (EU) single market in...
This study explores new product development in a strict regulatory and historically secretive enviro...
ObjectivesTo identify the potential opportunities and risks around future UK regulatory reform of me...
The EU medical device (MD) regulatory structure has changed from Directives to Regulations to ascer...
Background: Within the EU, some of the challenges and perceived risks now facing medical device (MD)...
The European Society for Biomaterials 2015 Translational Research Symposium focused on 'Innovating i...
Medical device software organisations face challenges not faced by generic software development orga...
ABSTRACT Introduction: Favoring innovation by making timely medical technology available to people ...
Technology is changing at a rapid rate, opening up new possibilities within the health care domain. ...
Recent achievements in respect of Artificial Intelligence (AI) open up opportunities for new tools t...
Objectives: The principal motivation for regulating medical devices is to protect patients and users...
Since 2010, two significant international regulations regarding medical device development have come...
Background: The background of this study is the change in regulatory frame-works for medical devices...
peer-reviewedMedical device software organisations face challenges not faced by generic software dev...
The Poly Implant Prothèse (PIP) scandal in France prompted a revision of the regulations regarding t...
Background Up until 2017, medical devices were placed on the European Union’s (EU) single market in...
This study explores new product development in a strict regulatory and historically secretive enviro...
ObjectivesTo identify the potential opportunities and risks around future UK regulatory reform of me...
The EU medical device (MD) regulatory structure has changed from Directives to Regulations to ascer...
Background: Within the EU, some of the challenges and perceived risks now facing medical device (MD)...
The European Society for Biomaterials 2015 Translational Research Symposium focused on 'Innovating i...
Medical device software organisations face challenges not faced by generic software development orga...
ABSTRACT Introduction: Favoring innovation by making timely medical technology available to people ...
Technology is changing at a rapid rate, opening up new possibilities within the health care domain. ...
Recent achievements in respect of Artificial Intelligence (AI) open up opportunities for new tools t...
Objectives: The principal motivation for regulating medical devices is to protect patients and users...
Since 2010, two significant international regulations regarding medical device development have come...
Background: The background of this study is the change in regulatory frame-works for medical devices...
peer-reviewedMedical device software organisations face challenges not faced by generic software dev...
The Poly Implant Prothèse (PIP) scandal in France prompted a revision of the regulations regarding t...
Background Up until 2017, medical devices were placed on the European Union’s (EU) single market in...
This study explores new product development in a strict regulatory and historically secretive enviro...